| View |
|
DRP-13127-07
|
Ketoanalogues + Essential Amino Acids
|
Alketo
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 April 2024
|
05 December 2027
|
| View |
DRP-13157-02_PI_01.pdf
|
DRP-13157-02
|
Levothyroxine sodium
|
Thyroxil
|
50 mcg
|
Tablet
|
Thyroid Hormone
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
18 April 2024
|
12 December 2027
|
| View |
|
DRP-13183-01
|
Cisplatin
|
None
|
500 mcg / mL (10 mg/20 mL)
|
Solution for IV Infusion
|
Antineoplastic agent (Platinum compound)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
16 December 2027
|
| View |
|
DRP-13190-02
|
Amlodipine (as besilate)
|
BPCheck 5
|
5 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 April 2024
|
16 December 2027
|
| View |
|
DRP-13229-12
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Javamet
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 April 2024
|
05 January 2028
|
| View |
|
DRP-13242-01
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Piptavast
|
4 g / 500 mg
|
Powder for Solution for Injection (I.V.)
|
Antibacterial (Penicillin with Beta-lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
15 April 2024
|
10 January 2028
|
| View |
|
DRP-1326-06
|
Cefuroxime (as sodium)
|
Xinatrene
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 April 2024
|
24 March 2029
|
| View |
|
DRP-13346-02
|
Epinephrine
|
Rexiphrine
|
1 mg/mL
|
Solution for Injection
|
Adrenergic and Dopaminergic Agent
|
Maxitech Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
10 April 2024
|
01 February 2028
|
| View |
|
DRP-13429-01
|
Dobutamine (as hydrochloride)
|
Dobutine
|
50 mg/mL (250 mg/ 5 mL)
|
Solution for Injection for I.V. Infusion
|
Cardiac Stimulant (Adrenergic and Dopaminergic Agent)
|
Swiss Parenterals Ltd. (Block B)
|
India
|
CLIDP Conversion
|
18 April 2024
|
16 February 2028
|
| View |
|
DRP-13459-01
|
Cefuroxime (as sodium)
|
Cefreexime
|
750 mg
|
Powder for Injection (IV/IM)
|
Antibacterial (Cephalosporin)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
25 April 2024
|
23 February 2028
|
| View |
|
DRP-13469-01
|
Mupirocin
|
Gorocin
|
20 mg/g (2% w/w)
|
Ointment
|
Antibacterial
|
Rhydburg Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
30 April 2024
|
23 February 2028
|
| View |
|
DRP-13469-02
|
Mupirocin
|
Mupiroskin
|
20 mg/g (2% w/w)
|
Ointment
|
Antibacterial
|
Rhydburg Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
27 April 2024
|
23 February 2028
|
| View |
|
DRP-13578-02
|
Moxifloxacin (as hydrochloride)
|
Ikshamox
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Solution
|
Antiinfective (Fluoroquinolone)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
13 March 2028
|
| View |
|
DRP-13579-01
|
Paracetamol + Caffeine
|
None
|
500 mg/65 mg
|
Tablet
|
Analgesic/Antipyretic
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 April 2024
|
13 March 2028
|
| View |
|
DRP-13585-02
|
Levetiracetam
|
Leptam Tab
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Zhejiang Jingxin Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
07 April 2024
|
14 March 2028
|
| View |
|
DRP-13645-03
|
Sitagliptin (as phosphate)
|
Janogen
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 April 2024
|
22 March 2028
|
| View |
|
DRP-13646-03
|
Sitagliptin (as phosphate)
|
Janogen
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
07 April 2024
|
22 March 2028
|
| View |
|
DRP-13685-01
|
Ceftriaxone (as sodium)
|
Cephamed
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
15 April 2024
|
28 March 2028
|
| View |
|
DRP-13687-05
|
Losartan Potassium
|
Arteva 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
18 April 2024
|
28 March 2028
|
| View |
|
DRP-13843-01
|
Gabapentin
|
Gobapen
|
300 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
28 April 2024
|
28 April 2028
|